Animal models of working memory: A review of tasks that might be used in screening drug treatments for the memory impairments found in schizophrenia

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 9, 2013, Pages 2111-2124

  Dudchenko, Paul A ^a   Talpos, John ^b   Young, Jared ^c   Baxter, Mark G ^d  

^a UNIVERSITY OF STIRLING   (United Kingdom)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; Delayed non matching to position; N Back; Odour span; Schizophrenia; Working memory

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; ASENAPINE; CHOLINESTERASE INHIBITOR; CLOZAPINE; GUANFACINE; HALOPERIDOL; ILOPERIDONE; METANICOTINE; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINIC AGENT; OLANZAPINE; PHYSOSTIGMINE; RISPERIDONE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ATTENTION DISTURBANCE; BRAIN DAMAGE; BRAIN DYSFUNCTION; COGNITIVE DEFECT; CONSENSUS; DISCRIMINANT VALIDITY; DISEASE ASSOCIATION; DISEASE MODEL; DRUG DEVELOPMENT; DRUG MEGADOSE; HUMAN; MEDICAL EXPERT; MEMORY DISORDER; MENTAL CAPACITY; MENTAL PERFORMANCE; MENTAL TASK; MENTAL TEST; MOLECULAR GENETICS; MOTIVATION; NEUROBIOLOGY; NEUROPROTECTION; NONHUMAN; PATIENT ASSESSMENT; PREDICTIVE VALIDITY; PRIMATE; PRIORITY JOURNAL; PSYCHOMETRY; REVIEW; SCHIZOPHRENIA; WORKING MEMORY;

ANIMAL MODELS; DELAYED NON-MATCHING TO POSITION; N-BACK; ODOUR SPAN; SCHIZOPHRENIA; WORKING MEMORY;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HUMANS; MEMORY DISORDERS; MEMORY, SHORT-TERM; SCHIZOPHRENIA;

EID: 84878259941     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2012.03.003     Document Type: Review

References (127)

1. Abi-Dargham A., Mawlawi O., Lombardo I., Gil R., Martinez D., Huang Y., Hwang D.R., Keilp J., Kochan L., Van Heertum R., Gorman J.M., Laruelle M. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J. Neurosci. 2002, 22(9):8-19.
2. Alexander G.E., Goldman P.S. Functional development of the dorsolateral prefrontal cortex: an analysis utilizing reversible cryogenic depression. Brain Res. 1978, 143:233-249.
3. Arnsten A.F.T., Cai J.X., Goldman-Rakic P.S. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes. J. Neurosci. 1988, 8:4287-4298.
4. Bachevalier J., Mishkin M. Visual recognition impairment follows ventromedial but not dorsolateral prefrontal lesions in monkeys. Behav. Brain Res. 1986, 20:249-261.
5. Baddeley A.D. Working memory: looking back and looking forward. Nat. Rev. Neurosci. 2003, 4:829-839.
6. Baddeley A.D., Hitch G. Working memory. The Psychology of Learning and Motivation: Advances in Research and Theory 1974, vol. 8:47-89. Academic Press, New York.
7. Ballard T.M., Woolley M.L., Prinssen E., Huwyler J., Porter R., Spooren W. The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison. Psychopharmacology (Berl.) 2005, 179:218-229.
8. Ballard T.M., Knoflach F., Prinssen E., Borroni E., Vivian J.A., Basile J., Gasser R., Moreau J.L., Wettstein J.G., Buettelmann B., Knust H., Thomas A.W., Trube G., Hernandez M.C. RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors. Psychopharmacology (Berl.) 2009, 202:207-223.
9. Barch D.M., Carter C.S., MacDonald A.W., Braver T.S., Cohen JD Context-processing deficits in schizophrenia: diagnostic specificity, 4-week course, and relationships to clinical symptoms. J. Abnorm. Psychol. 2003, 112:132-143.
10. Barch D.M., Smith E. The cognitive neuroscience of working memory: relevance to CNTRCS and schizophrenia. Biol. Psych. 2008, 64:11-17.
11. Baron S.P., Wright D., Wenger G.R. Effects of drugs of abuse and scopolamine on memory in rats: delayed spatial alternation and matching to position. Psychopharmacology (Berl.) 1998, 137:7-14.
12. Bartus R.T., Johnson H.R. Short-term memory in the rhesus monkey: disruption from the anticholinergic scopolamine. Pharmacol. Biochem. Behav. 1976, 5:31-39.
13. Bartus R.T. Physostigmine and recent memory: effects in young and aged nonhuman primates. Science 1979, 206:1087-1089.
14. Beason-Held L.L., Rosene D.L., Killiany R.J., Moss M.B. Hippocampal formation lesions produce memory impairment in the rhesus monkey. Hippocampus 1999, 9:562-574.
15. Boulougouris V., Dalley J.W., Robbins T.W. Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat. Behav. Brain Res. 2007, 179:219-228.
16. Brahmbhatt S.B., Haut K., Csernansky J.G., Barch D.M. Neural correlates of verbal and nonverbal working memory deficits in individuals with schizophrenia and their high-risk siblings. Schizophr. Res. 2006, 87:191-204.
17. Broersen L.M., Heinsbroek R.P., de Bruin J.P., Joosten R.N., van H.A., Olivier B. Effects of local application of dopaminergic drugs into the dorsal part of the medial prefrontal cortex of rats in a delayed matching to position task: comparison with local cholinergic blockade. Brain Res. 1994, 645:113-122.
18. Broersen L.M., Heinsbroek R.P., de Bruin J.P., Uylings H.B., Olivier B. The role of the medial prefrontal cortex of rats in short-term memory functioning: further support for involvement of cholinergic, rather than dopaminergic mechanisms. Brain Res. 1995, 674:221-229.
19. Brozoski T.J., Brown R.M., Rosvold H.E., Goldman P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979, 205:929-932.
20. Bures J., Fenton A.A., Kaminsky Y., Rossier J., Sacchetti B., Zinyuk L. Dissociation of exteroceptive and idiothetic orientation cues: effect on hippocampal place cells and place navigation. Philos. Trans. R Soc. Lond. B Biol. Sci. 1997, 352:1515-1524.
21. Bussey T.J., Padain T.L., Skillings E.A., Winters B.D., Morton A.J., Saksida L.M. The touchscreen cognitive testing method for rodents: how to get the best out of your rat. Learn. Mem. 2008, 15:516-523.
22. Bussey T.J., Holmes A., Lyon L., Mar A.C., McAllister K.A., Nithianantharajah J., Oomen C.A., Saksida L.M. New translational assays for preclinical modelling of cognition in schizophrenia: The touchscreen testing method for mice and rats. Neuropharmacology 2010, 10.1016/j.neuropharm.2011.04.011.
23. Campbell U.C., Lalwani K., Hernandez L., Kinney G.G., Conn P.J., Bristow L.J. The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats. Psychopharmacology (Berl.) 2004, 175:310-318.
24. Carter C.S., Mintun M., Nichols T., Cohen J.D. Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O] H2O PET study during single-trial stroop task performance. Am. J. Psych. 1997, 154:1670-1675.
25. Chey J., Lee J., Kim Y-S., Kwon S-M., Shin Y-M. Spatial working memory span, delayed response and executive function in schizophrenia. Psych. Res. 2002, 110:259-271.
26. Chiba A.A., Kesner R.P., Gibson C.J. Memory for temporal order of new and familiar spatial location sequences: role of the medial prefrontal cortex. Learn. Mem. 1997, 4:311-317.
27. Chiba A.A., Kesner R.P., Jackson P.A. Two forms of spatial memory: a double dissociation between the parietal cortex and the hippocampus in the rat. Behav. Neurosci. 2002, 116(5):874-883.
28. Chudasama Y., Muir J.L. A behavioural analysis of the delayed non-matching to position task: the effects of scopolamine, lesions of the fornix and of the prelimbic region on mediating behaviours by rats. Psychopharmacology (Berl.) 1997, 134:73-82.
29. Cimadevilla J.M., Kaminsky Y., Fenton A., Bures J. Passive and active avoidance as a tool of spatial memory research in rats. J. Neurosci. Methods 2000, 102:155-164.
30. Cohen J.D., Perlstein W.M., Braver T.S., Nystrom L.E., Noll D.C., Jonides J., Smith E.E. Temporal dynamics of brain activation during a working memory task. Nature 1997, 386:604-608.
31. Cole B.J., Klewer M., Jones G.H., Stephens D.N. Contrasting effects of the competitive NMDA antagonist CPP and the non-competitive NMDA antagonist MK 801 on performance of an operant delayed matching to position task in rats. Psychopharmacology (Berl.) 1993, 111:465-471.
32. Croxson P.L., Kyriazis D.A., Baxter M.G. Cholinergic modulation of a specific memory function of prefrontal cortex. Nat. Neurosci. 2011, 14:1510-1512.
33. Deadwyler S.A., Bunn T., Hampson R.E. Hippocampal ensemble activity during spatial delayed-nonmatch-to-sample performance in rats. J. Neurosci. 1996, 16:354-372.
34. Deadwyler S.A., Hampson R.E. Differential but complementary mnemonic functions of the hippocampus and subiculum. Neuron 2004, 42:465-476.
35. DeVito L.M., Eichenbaum H. Memory for the order of events in specific sequences: contributions of the hippocampus and the medial prefrontal cortex. J. Neurosci. 2011, 31:3169-3175.
36. Dudchenko P.A., Wood E.R., Eichenbaum H. Neurotoxic hippocampal lesions have no effect on odor span and little effect on odor recognition memory but produce significant impairments on spatial span, recognition, and alternation. J. Neurosci. 2000, 20:2964-2977.
37. Dunnett S.B., Evenden J.L., Iversen S.D. Delay-dependent short-term memory deficits in aged rats. Psychopharmacology (Berl.) 1988, 96:174-180.
38. Dunnett S.B., Martel F.L. Proactive interference effects on short-term memory in rats: I. Basic parameters and drug effects. Behav. Neurosci. 1990, 104:655-665.
39. Dunnett S.B., Wareham A.T., Torres E.M. Cholinergic blockade in prefrontal cortex and hippocampus disrupts short-term memory in rats. Neuroreport 1990, 1:61-64.
40. Eagle D.M., Bari A., Robbins T.W. The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berl.) 2008, 199:439-456.
41. Fellini, L., Talpos, J., Steckler, T., 2011. The conditional delayed matching and non-matching to position task: a valuable alternative to the traditional delayed non-matching to position paradigm? Society for Neuroscience Abstracts, 96.21.
42. Flagstad P., Glenthoj B.Y., Didriksen M. Cognitive deficits caused by late gestational disruption of neurogenesis in rats: a preclinical model of schizophrenia. Neuropsychopharmacology 2005, 30:250-260.
43. Fortin N.J., Agster K.L., Eichenbaum H.B. Critical role of the hippocampus for memory for sequences of events. Nat. Neurosci. 2002, 5:458-462.
44. Funahashi S., Bruce C.J., Goldman-Rakic P.S. Mnemonic coding of visual space in the primate dorsolateral prefrontal cortex. J. Neurophysiol. 1989, 61:331-349.
45. Fuster J.M., Alexander G.E. Neuron activity related to short-term memory. Science 1971, 173:652-654.
46. Gemperle A.Y., McAllister K.H., Olpe H.R. Differential effects of iloperidone, clozapine, and haloperidol on working memory of rats in the delayed non-matching-to-position paradigm. Psychopharmacology (Berl.) 2003, 169:354-364.
47. Gevins A., Cutillo B. Spatiotemporal dynamics of component processes in human working memory. Electroencephalogr. Clin. Neurophysiol. 1993, 87(3):128-143.
48. Glahn D.C., Ragland J.D., Abramoff A., Barrett J., Laird A.R., Bearden C.E., Velligan D.I. Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Human Brain Map. 2005, 25(1):60-69.
49. Gold J.M., Hahn B., Zhang W.W., Robinson B.M., Kappenman M.A., Beck V.M., Luck S.J. Reduced capacity but spared precision and maintenance of working memory representations in schizophrenia. Arch. Gen. Psych. 2010, 67(6):570-577.
50. Goldman P.S., Rosvold H.E. Localization of function within the dorsolateral prefrontal cortex of the rhesus monkey. Exp. Neurol. 1970, 27:291-304.
51. Goldman-Rakic P.S. Working memory dysfunction in schizophrenia. J. Neuropsych. Clin. Neurosci. 1994, 6:348-357.
52. Green M.F., Kern R.S., Braff D.L., Mintz J. Neurocognitive deficits and functional outcome in Schizophrenia: are we measuring the right stuff?. Schizophr. Bull. 2000, 26(1):119-136.
53. Haddon J.E., Killcross A.S. Prefrontal cortex lesions disrupt the contextual control of response conflict. J. Neurosci. 2006, 26:2933-2940.
54. Haddon J.E., Killcross A.S. Contextual control of choice performance: Behavioral, neurobiological, and neurochemical influences. Ann. N. Y. Acad. Sci. 2007, 1104:250-269.
55. Hampson R.E., Deadwyler S.A. Temporal firing characteristics and the strategic role of subicular neurons in short-term memory. Hippocampus 2003, 13:529-541.
56. Hampson R.E., Hedberg T., Deadwyler S.A. Differential information processing by hippocampal and subicular neurons. Ann. N. Y. Acad. Sci. 2000, 911:151-165.
57. Hampson R.E., Heyser C.J., Deadwyler S.A. Hippocampal cell firing correlates of delayed-match-to-sample performance in the rat. Behav. Neurosci. 1993, 107:715-739.
58. Hampson R.E., Simeral J.D., Deadwyler S.A. Distribution of spatial and nonspatial information in dorsal hippocampus. Nature 1999, 402:610-614.
59. Hampton R.R., Hampstead B.M., Murray E.A. Selective hippocampal damage in rhesus monkeys impairs spatial memory in an open-field test. Hippocampus 2004, 14:808-818.
60. Henik A., Salo R. Schizophrenia and the stroop effect. Behav. Cogn. Neurosci. Rev. 2004, 3:42-59.
61. Herremans A.H., Hijzen T.H., Welborn P.F., Olivier B., Slangen J.L. Effects of infusion of cholinergic drugs into the prefrontal cortex area on delayed matching to position performance in the rat. Brain Res. 1996, 711:102-111.
62. Heuer E., Bachevalier J. Effects of selective neonatal hippocampal lesions on tests of object and spatial recognition memory in monkeys. Behav. Neurosci. 2011, 125:137-149.
63. Higgins G.A., Ballard T.M., Kew J.N., Richards J.G., Kemp J.A., Adam G., Woltering T., Nakanishi S., Mutel V. Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent. Neuropharmacology 2004, 46:907-917.
64. Higgins G.A., Ballard T.M., Enderlin M., Haman M., Kemp J.A. Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat. Psychopharmacology (Berl.) 2005, 179:85-98.
65. Honig W.K. Studies of working memory in the pigeon. Cognitive Processes in Animal Behavior 1978, 211-248. Lawrence Erlbaum Associates, Hillsdale. W.K. Honig (Ed.).
66. Hoyle E., Genn R.F., Fernandes C., Stolerman I.P. Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task. Psychopharmacology (Berl.) 2006, 189(2):211-223.
67. Jackson-Smith P., Kesner P., Chiba A.A. Continuous recognition of spatial and nonspatial stimuli in hippocampal-lesioned rats. Behav. Neural Biol. 1993, 59:107-119.
68. Jarskog L.F., Robbin T.W. Neuropathology and neural circuits implicated in schizophrenia. The American Psychiatric Publishing textbook of schizophrenia 2006, American Psychiatric Publishing, Arlington, Virginia. J.A. Lieberman, T. Scott Stroup, D.O. Perkins (Eds.).
69. Kesner R.P., Dakis M. Intrahippocampal injections of phencyclidine but not naloxone disrupt acquisition of a spatial continuous recognition memory task. Pharmacology. Biochem. Behav. 1997, 56(1):97-101.
70. Kesner R.P., Ragozzino M. Pharmacological approaches to animal models of human working memory and shifting attentional set. Commentary on Robbins' homology in behavioral pharmacology: An approach to animal models of human cognition. Behav. Pharmacol. 1998, 9:521-524.
71. Kesner R.P., Ravindranathan A., Jackson P., Giles R., Chiba A.A. A neural circuit analysis of visual recognition memory: role of perirhinal, medial, and lateral entorhinal cortex. Learn. Mem. 2001, 8:87-95.
72. Kirchner W.K. Age differences in short-term retention of rapidly changing information. J. Exp. Psychol. 1958, 55:352-358.
73. Klinkenberg I., Blokland A. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci. Biobehav. Rev. 2010, 34:1307-1350.
74. Ko T., Evenden J. The effects of psychotomimetic and putative cognitive-enhancing drugs on the performance of a n-back working memory task in rats. Psychopharmacology (Berl.) 2009, 202(1-3):67-78.
75. Krueger D.D., Howell J.L., Hebert B.F., Olausson P., Taylor J.R., Nairn A.C. Assessment of cognitive function in the heterozygous reeler mouse. Psychopharmacology (Berl.) 2006, 189:95-104.
76. Kubota K., Niki H. Prefrontal cortical unit activity and delayed alternation performance in monkeys. J. Neurophysiol. 1971, 34:337-347.
77. Lee J., Park S. Working memory impairments in schizophrenia: a meta-analysis. J. Abnorm. Psychol. 2005, 114(4):599-611.
78. Levy D.A., Manns J.R., Hopkins R.O., Gold J.J., Broadbent N.J., Squire L.R. Impaired visual and odor recognition memory span in patients with hippocampal lesions. Learn. Mem. 2003, 10(6):531-536.
79. Long J.M., Kesner R.P. Phencyclidine impairs temporal order memory for spatial locations in rats. Pharmacol. Biochem. Behav. 1995, 52(3):645-648.
80. Luck S.J., Vogel E.K. The capacity of visual working memory for features and conjunctions. Nature 1997, 390:279-281.
81. Maguire E.A., Burgess N., O'Keefe J. Human spatial navigation: cognitive maps, sexual dimorphism, and neural substrates. Curr. Opin. Neurobiol. 1999, 9:171-177.
82. Mao J.B., Robinson J.K. Microinjection of GABA-A agonist muscimol into the dorsal but not the ventral hippocampus impairs non-mnemonic measures of delayed non-matching-to-position performance in rats. Brain Res. 1998, 784:139-147.
83. Marquis J-P., Killcross A.S., Haddon J.E. Inactivation of the prelimbic cortex, but not the infralimbic cortex, impairs contextual control of response conflict in rats. Eur. J. Neurosci. 2007, 25:559-566.
84. Marston H.M., Young J.W., Martin F.D., Serpa K.A., Moore C.L., Wong E.H., Gold L., Meltzer L.T., Azar M.R., Geyer M.A., Shahid M. Asenapine effects in animal models of psychosis and cognitive function. Psychopharmacology (Berl.) 2009, 206:699-714.
85. Miller G.A. The magical number seven, plus or minus two: some limits on our capacity for processing information. Psychol. Rev. 1956, 63:81-97.
86. Mishkin M., Vest B., Waxler M., Rosvold H.E. A re-examination of the effects of frontal lesions on object alternation. Neuropsychologia 1969, 7:357-363.
87. Mishkin M., Delacour J. An analysis of short-term visual memory in the monkey. J. Exp. Psychol.: Anim. Behav. Process. 1975, 1:326-334.
88. Mumby D.G., Pinel J.P.J., Kornecook T.J., Shen M.J., Redila V.A. Memory deficits following lesions of hippocampus or amygdale in rat: Assessment by an object-memory test battery. Psychobiology 1995, 23(1):26-36.
89. Murray E.A., Mishkin M. Object recognition and location memory in monkeys with excitotoxic lesions of the amygdala and hippocampus. J. Neurosci. 1998, 18:6568-6582.
90. Olton D.S., Becker J.T., Handelmann G.E. Hippocampus, space, and memory. Behav. Brain Sci. 1979, 2:313-365.
91. Olton D.S., Samuelson R.J. Remembrance of places passed: spatial memory in rats. J. Exp. Psychol.: Anim. Behav. Process. 1976, 2:97-116.
92. Pache D.M., Sewell R.D.E., Spencer P.S.J. Detecting drug effects on short-term memory function using a combined delayed matching and non-matching to position task - effect of scopolamine, 8-OH-DPAT and EAA antagonists. J. Pharm. Toxicol. Meth. 1999, 41:135-141.
93. Pirkola T., Tuulio-Henriksson A., Glahn D., Kieseppä T., Haukka J., Kaprio J., Lönnqvist J., Cannon T.D. Spatial working memory function in twins with schizophrenia and bipolar disorder. Biol. Psych. 2005, 58:930-936.
94. Pitkanen M., Sirvio J., MacDonald E., Ekonsalo T., Riekkinen P. The effects of d-cycloserine, a partial agonist at the glycine binding site, on spatial learning and working memory in scopolamine-treated rats. J. Neural Trans.Park Dis. Dement. Sect. 1995, 9:133-144.
95. Porter M.C., Burk J.A., Mair R.G. A comparison of the effects of hippocampal or prefrontal cortical lesions on three versions of delayed non-matching-to-sample based on positional or spatial cues. Behav. Brain Res. 2000, 109:69-81.
96. Prieto, L., Taboada Martinez, L., 2011. Tetrahydrotriazolopyridine compounds as selective MGLU5 receptor potentiators useful for the treatment of schizophrenia. World Intellectual Property Organization Patent No. WO/2011/082010.
97. Rapp P.R., Amaral D.G. Evidence for task-dependent memory dysfunction in the aged monkey. J. Neurosci. 1989, 9:3568-3576.
98. Redish A.D., Battaglia F.P., Chawla M.K., Ekstrom A.D., Gerrard J.L., Lipa P., Rosenzweig E.S., Worley P.F., Guzowski J.F., McNaughton B.L., Barnes C.A. Independence of firing correlates of anatomically proximate hippocampal pyramidal cells. J. Neurosci. 2001, 21:RC134.
99. Robinson J.K., Mao J.B. Differential effects on delayed non-matching-to-position in rats of microinjections of muscarinic receptor antagonist scopolamine or NMDA receptor antagonist MK-801 into the dorsal or ventral extent of the hippocampus. Brain Res. 1997, 765:51-60.
100. Roberts W.A. Short-term memory in the pigeon: effects of repetition and spacing. J. Exp. Psych. 1972, 94:74-83.
101. Rushforth S.L., Allison C., Wonnacott S., Shoaib M. Subtype-selective nicotinic agonists enhance olfactory working memory in normal rats: a novel use of the odour span task. Neurosci. Lett. 2010, 471:114-118.
102. Sahgal A. Contrasting effects of vasopressin, desglycinamide-vasopressin and amphetamine on a delayed matching to position task in rats. Psychopharmacology (Berl.) 1987, 93:243-249.
103. Sahgal A., Keith A.B., Lloyd S. Opposing effects of vasopressin on matching versus non-matching to position: further evidence for response, not memory, modulation. Psychopharmacology (Berl.) 1990, 102:130-135.
104. Sarter M. Preclinical research into cognition enhancers. Trends Pharmacol. Sci. 2006, 27:602-608.
105. Sarter M., Hagan J., Dudchenko P. Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part 1. Psychopharmacology 1992, 107:144-159.
106. Savage S., Kehr J., Olson L., Mattsson A. Impaired social interaction and enhanced sensitivity to phencyclidine-induced deficits in novel object recognition in rats with cortical cholinergic denervation. Neuroscience 2011, 195:60-69.
107. Servan-Schreiber D., Cohen J.D., Steingard S. Schizophrenic deficits in the processing of context: a test of a theoretical model. Arch. Gen. Psych. 1996, 53:1105-1112.
108. Shenton M.E., Dickey C.C., Frumin M., McCarley R.W. A review of MRI findings in schizophrenia. Schizophr. Res. 2001, 49:1-52.
109. Sloan H.L., Dobrossy M., Dunnett S.B. Hippocampal lesions impair performance on a conditional delayed matching and non-matching to position task in the rat. Behav. Brain Res. 2006, 171:240-250.
110. Sloan H.L., Good M., Dunnett S.B. Double dissociation between hippocampal and prefrontal lesions on an operant delayed matching task and a water maze reference memory task. Behav. Brain Res. 2006, 171:116-126.
111. Smith J.W., Gastambide F., Gilmour G., Dix S., Foss J., Lloyd K., Malik N., Tricklebank M. A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory. Psychopharmacology (Berl.) 2011, 217:255-269.
112. Steele K., Rawlins J.N.P. Rats remember long lists of nonspatial items. Psychobiology 1989, 17:450-452.
113. Takahashi M., Lauwereyn J., Sakurai Y., Tsukada M. A code for spatial alternation during fixation in rat hippocampal CA1 neurons. J. Neurophysiol. 2009, 102:556-567.
114. Talpos J.C., McTighe S.M., Dias R., Saksida L.M., Bussey T.J. Trial-unique, delayed nonmatching-to-location (TUNL): a novel, highly hippocampus-dependent automated touchscreen test of location memory and pattern separation. Neurobiol. Learn. Mem. 2010, 94:341-352.
115. Turchi J., Sarter M. Cortical cholinergic inputs mediate processing capacity: effects of 192 IgG-saporin-induced lesions on olfactory span performance. Eur. J. Neurosci. 2000, 12:4505-4514.
116. Young J.W., Crawford N., Kelly J.S., Kerr L.E., Marston H.M., Spratt C., Finlayson K., Sharkey J. Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. Eur. J. Neuropsychopharmacol. 2007, 17(2):145-155.
117. Young J.W., Finlayson K., Spratt C., Marston H.M., Crawford N., Kelly J.S., Sharkey J. Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor. Neuropsychopharmacology 2004, 29(5):891-900.
118. Young J.W., Kerr L.E., Kelly J.S., Marston H.M., Spratt C., Finlayson K., Sharkey J. The odour span task: a novel paradigm for assessing working memory in mice. Neuropharmacology 2007, 52:634-645.
119. Young J.W., Powell S., Risbrough V., Marston H.M., Geyer M.A. Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol. Ther. 2009, 122:150-202.
120. Young J.W., Sharkey J., Finlayson K. Progressive impairment in olfactory working memory in a mouse model of Mild Cognitive Impairment. Neurobiol. Aging 2008, 30:1430-1443.
121. Young B.J., Otto T., Fox G.D., Eichenbaum H. Memory representation within the parahippocampal region. J. Neurosci. 1997, 17:5183-5195.
122. Vales K., Bubenikova-Valesova V., Klement D., Stuchlik A. Analysis of sensitivity to MK-801 treatment in a novel active allothetic place avoidance task and in the working memory version of the Morris water maze reveals differences between Long-Evans and Wistar rats. Neurosci. Res. 2006, 55:383-388.
123. van Hest A., Steckler T. Effects of procedural parameters on response accuracy: lessons from delayed (non-)matching procedures in animals. Brain Res.: Cogn. Brain Res. 1996, 3:193-203.
124. Wang M., Gamo N.J., Yang Y., Jin L.E., Wang X-J., Laubach M., Mazer J.A., Lee D., Arnsten A.F.T. Neuronal basis of age-related working memory decline. Nature 2011, 476:210-213.
125. Willmore C.B., LaVecchia K.L., Wiley J.L. NMDA antagonists produce site-selective impairment of accuracy in a delayed nonmatch-to-sample task in rats. Neuropharmacology 2001, 41:916-927.
126. Winters B.D., Dunnett S.B. Selective lesioning of the cholinergic septo-hippocampal pathway does not disrupt spatial short-term memory: a comparison with the effects of fimbria-fornix lesions. Behav. Neurosci. 2004, 118:546-562.
127. Woltering T.J., Wichmann J., Goetschi E., Knoflach F., Ballard T.M., Huwyler J., Gatti S. Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 4. In vivo active potent and selective non-competitive metabotropic glutamate receptor 2/3 antagonists. Bioorg. Med. Chem. Lett. 2010, 20:6969-6974.